Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Oct 27;11(11):1647.
doi: 10.3390/vaccines11111647.

Role of Immunoglobulin A in COVID-19 and Influenza Infections

Rohit Tyagi  1 , Srijani Basu  2 , Atika Dhar  3 , Suman Gupta  4 , Sneh Lata Gupta  5 , Rishi K Jaiswal  6
Affiliations
Editorial

Role of Immunoglobulin A in COVID-19 and Influenza Infections

Rohit Tyagi et al. Vaccines (Basel). .

Abstract

Immunoglobulin A (IgA) is critical in the immune response against respiratory infections like COVID-19 and influenza [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Various vaccine strategies being developed against Influenza and SARS-CoV-2. Both virues have distinct surface protein structure which have been used to detect and classify various viral strains. The current vaccinestrategies include utilizing different approaches to elicit prolonged neutralizing antibodytiters.
See this image and copyright information in PMC

References

    1. Gupta S.L., Jaiswal R.K. Relevant of neutralizing antibody during SARS-CoV-2 infection and their therapeutic usage. Mol. Biol. Rep. 2022;49:10137–10140. doi: 10.1007/s11033-022-07493-z. - DOI - PMC - PubMed
    1. Zorgi N.E., Meireles L.R., Oliveira D.B.L., Araujo D.B., Durigon E.L., de Andrade Junior H.F. Isolated specific IgA against respiratory viruses, Influenza or SARS-CoV-2, present in the saliva of a fraction of healthy and asymptomatic volunteers. Clinics. 2022;77:100105. doi: 10.1016/j.clinsp.2022.100105. - DOI - PMC - PubMed
    1. Sterlin D., Mathian A., Miyara M., Mohr A., Anna F., Claër L., Quentric P., Fadlallah J., Devilliers H., Ghillani P., et al. IgA dominates the early neutralizing antibody response to SARS-CoV-2. Sci. Transl. Med. 2021;13:eabd2223. doi: 10.1126/scitranslmed.abd2223. - DOI - PMC - PubMed
    1. Quinti I., Mortari E.P., Fernandez Salinas A., Milito C., Carsetti R. IgA Antibodies and IgA Deficiency in SARS-CoV-2 Infection. Front. Cell. Infect. Microbiol. 2021;11:655896. doi: 10.3389/fcimb.2021.655896. - DOI - PMC - PubMed
    1. Montague B.T., Wipperman M.F., Chio E., Crow R., Hooper A.T., O’Brien M.P., Simões E.A.F. Elevated serum IgA following vaccination against SARS-CoV-2 in a cohort of high-risk first responders. Sci. Rep. 2022;12:14932. doi: 10.1038/s41598-022-19095-7. - DOI - PMC - PubMed

Publication types

LinkOut - more resources